SCHEMBL26869656

SCHEMBL26869656

C/C=C1\C(=O)N(C)c2cc(F)ccc2N1C1CCNCC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 2/20 0.36
GRIA2 P42262 2/20 0.36
GRIA3 P42263 2/20 0.36
GRIA4 P48058 2/20 0.36
OPRM1 P35372 3/20 0.35
OPRL1 P41146 3/20 0.35
OPRK1 P41145 1/20 0.34
PARP2 Q9UGN5 1/20 0.34
PARP3 Q9Y6F1 1/20 0.34
HTR2C P28335 3/20 0.33
HTR2B P41595 3/20 0.33
CDK9 P50750 1/20 0.32
CCR3 P51677 1/20 0.32
NUAK1 O60285 1/20 0.32
TP53 P04637 1/20 0.32
HTR1A P08908 1/20 0.32
SLC6A2 P23975 1/20 0.32
SLC6A4 P31645 1/20 0.32
SLC6A3 Q01959 1/20 0.32
TLR8 Q9NR97 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10063154 0.72 OPRM1 (0.42) GRIA1GRIA2GRIA3GRIA4OPRM1
SCHEMBL10063160 0.72 OPRM1 (0.42) OPRM1OPRL1OPRK1PARP2PARP3
SCHEMBL3380254 0.68 OXTR (0.41) OPRM1OPRL1HTR2CHTR2B
SCHEMBL10062766 0.68 OPRM1 (0.43) OPRM1OPRL1OPRK1HTR2CHTR2B
SCHEMBL181875 0.68 OPRM1 (0.36) GRIA1GRIA2GRIA3GRIA4OPRM1
SCHEMBL3381685 0.68 OXTR (0.41) HTR2CHTR2B
SCHEMBL5546064 0.68 CCR3 (0.38) GRIA1GRIA2GRIA3GRIA4OPRM1
SCHEMBL7414811 0.68 HTR2C (0.48) OPRM1OPRL1OPRK1HTR2CHTR2B
SCHEMBL20230166 0.67 IDO1 (0.37) PARP2PARP3HTR2CHTR2BCDK9
SCHEMBL15202948 0.65 HTR2C (0.42) GRIA1GRIA2GRIA3GRIA4OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023229375-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO disclosed